CDDF’s New Board Members: A Warm Welcome to Dr. Christian Schneider, Dr. Fergus Sweeney and Dr. Rosa Giuliani
With great pleasure, the Cancer Drug Development Forum (CDDF) announces the appointment of Dr. Christian Schneider, Dr. Fergus Sweeney, and Dr. Rosa Giuliani to its Board of Directors for a three-year term, effective 5 December, 2023. We warmly welcome these new...
Executive Summary of the CDDF Workshop on Biomarkers in Precision Oncology (13-14 Nov 2023, NL)
The Cancer Drug Development Forum (CDDF) is delighted to announce that its executive summary of the CDDF workshop on Biomarkers in Precision Oncology (13-14 Nov 2023, NL) has been published and is available to all our stakeholders. This insightful workshop brought...
TAKE-HOME MESSAGES: CDDF Multi-Stakeholder Workshop – The Critical Role of Biomarkers in Delivering Drug Development-Related Precision Oncology
Read the take-home messages from the CDDF multi-stakeholder workshop on The critical role of Biomarkers in delivering drug development-related precision oncology: SESSION 1: SETTING THE SCENE OF BIOMARKERS Key takeaways: Biomarkers are critical in the diagnosis...